Press Releases

All amounts expressed in Canadian dollars unless otherwise noted

Toronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - May 8, 2024) - PharmaCielo Ltd. (TSXV: PCLO) (OTCQX: PCLOF) ("PharmaCielo" or the "Company"), the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., today announced that the Ontario Securities Commission (the "OSC"), as its principal regulator,... (continue reading...)

First Quarter 2024 Results

• Revenue was $476.3 million, an increase of 7.0% as compared to the same period in the prior year
• Net income was $34.8 million, an increase of 40.3% as compared to the same period in the prior year
• Net income attributable to common unitholders was $34.2 million, or $1.50 per diluted common unit
• Adjusted EBITDA* totaled $58.6 million; Adjusted EBITDA margin* was 12.3%
• Net cash provided by operating activities was $197.5... (continue reading...)

Total Revenue Increased 25% to $51.3 Million

Record First Quarter MACI Revenue of $40.2 Million and Burn Care Revenue Growth of 63%

Adjusted EBITDA Growth of 325%

Full-Year 2024 Revenue Guidance Raised to $238-$242 Million

Conference Call Today at 8:30am Eastern Time

CAMBRIDGE, Mass., May 08, 2024 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ: VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today reported financial... (continue reading...)

• Revenue of €379.3 million for the first quarter of 2024, representing the highest revenue recorded in a first quarter
• Profit for the three months ended March 31, 2024 of €41.0 million, including a pre-tax gain of €40.1 million relating to the sale of the B2B division of DGC and a non-cash charge of €13.1 million for change in fair value of option liability
• Non-GAAP Adjusted EBITDA ex-US of €68.7 million and a loss of €22.3 million from the US... (continue reading...)

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)

1.        KEY INFORMATION